• APEX2 Enables TERT Expression in Human Stem Cells

  2026-08-20

  The reference preprint identifies APEX2 as a DNA repair enzyme required for efficient TERT expression and telomerase activity in human embryonic stem cells, distinguishing its role from the related enzyme APEX1. By combining knockdown, RNA sequencing, and chromatin immunoprecipitation, the study links APEX2-dependent transcription to damage-prone repetitive DNA, particularly MIR elements within the TERT locus.

• Engineering a Single-Component Spiramycin Producer

  2026-08-20

  The reference study used an in-frame partial deletion of the sspA 3-O-acyltransferase gene to redirect a recombinant Streptomyces spiramyceticus strain toward 4''-isovalerylspiramycin I. This targeted pathway edit reduced the component complexity of bitespiramycin and provides a useful model for improving consistency in macrolide antibiotic production.

• Aclacinomycin A: A Nucleolar DNA Damage Probe

  2026-08-19

  Aclacinomycin A, also called Aclarubicin, is examined here as more than a cytotoxic anthracycline: it is a potential probe for linking topological stress, persistent rDNA lesions, PML-nucleolar associations, and apoptosis. This article translates recent nucleolar DNA-repair findings into practical assay-design decisions while defining the limits of the evidence.

• BHQ for SERCA Calcium Signaling Research

  2026-08-19

  Learn how 2,5-di-tert-butylbenzene-1,4-diol (BHQ) can connect SERCA inhibition, ER calcium-store depletion, and HSC mobilization assays. This practical guide covers stock preparation, calcium readouts, CXCR4-focused validation, vascular applications, and troubleshooting controls.

• Midecamycin: Applied Workflows for Antibacterial Research

  2026-08-18

  Midecamycin combines a defined 23S rRNA mechanism with strong Gram-positive activity, making it useful for MIC testing, protein-synthesis studies, and macrolide resistance workflows. This guide translates its solubility, concentration range, glycosylation sensitivity, and exposure-response considerations into practical bench strategies.

• Topological Stress, rDNA Lesions, and PML Compartments

  2026-08-18

  Urbancokova, Hornofova and colleagues identify persistent ribosomal DNA damage as a direct trigger of PML-nucleolar associations, linking topological stress, RNA polymerase I inhibition, and incomplete homologous recombination. The study provides a useful experimental framework for separating rDNA-specific damage responses from general DNA double-strand break signaling.

• IgSF6, ER Stress, and Intestinal Defense

  2026-08-17

  The reference study shows that the endoplasmic-reticulum protein IgSF6 restrains IRE1α–XBP1 signaling and reactive oxygen species production in intestinal macrophages. Although IgSF6 deficiency improves antibacterial activity during Salmonella challenge, it also increases susceptibility to DSS-induced colitis, revealing a trade-off between pathogen clearance and intestinal homeostasis.

• Chlorambucil: Separating Arrest From Cell Death

  2026-08-17

  Chlorambucil is a nitrogen mustard alkylating agent whose DNA damage can produce both growth arrest and cell killing. This guide shows how to distinguish those outcomes in chronic lymphocytic leukemia treatment research and other in vitro models.

• HyperScribe All in One mRNA Synthesis Kit Guide

  2026-08-16

  Build reproducible ARCA-capped, polyadenylated mRNA workflows for vaccine research, translation assays, and functional RNA studies. This practical guide connects kit design with spleen-targeted neoantigen vaccine findings while emphasizing controllable preparation, QC, and troubleshooting.

• Dovitinib (TKI-258) Workflow for Cancer Research

  2026-08-15

  Dovitinib (TKI-258) enables mechanism-focused studies of RTK signaling, apoptosis, and treatment resistance across cancer models. This guide translates its multitarget profile into practical cell-based workflows and shows how multimodal radiopathomics can sharpen biomarker-driven experimental design.

• Latrunculin A and the Actin–Myosin II Axis

  2026-08-14

  Latrunculin A is more than a laboratory actin polymerization inhibitor: its reversible control of G-actin availability provides a strategic way to test how cytoskeletal architecture supports cell movement, morphology, and viral proliferation. This article connects product-level mechanism with recent proteomic evidence linking the actin–myosin II network to duck enteritis virus biology and outlines a disciplined translational workflow.

• Lipid Nanoparticle Trafficking and Endosomal Escape

  2026-08-14

  The reference study shows that efficient lipid nanoparticle delivery depends on more than cellular uptake: excessive accumulation in peripheral endosomes can block movement toward perinuclear lysosomal regions and reduce cytosolic release. By combining sensitive nanoparticle labeling with controlled endolysosomal states, the authors connect nutrient-regulated activity, intracellular trafficking, compartment saturation, and transgene expression.

• Rocket-Like Nanomedicine Reprograms Pancreatic Tumor Stroma

  2026-08-13

  The reference study develops an acid-responsive, sequential-release nanoplatform that combines stromal reprogramming with gemcitabine delivery for pancreatic ductal adenocarcinoma. In a PDAC mouse model, the Si-G@Ca-H/uPA formulation produced marked tumor regression without reported side effects, supporting stromal homeostasis as a strategy for improving chemotherapy access.

• Midecamycin: Findings from a 1983 In Vitro Study

  2026-08-13

  Harold C. Neu’s 1983 study systematically characterized the in vitro spectrum of midecamycin across clinically derived Gram-positive and Gram-negative isolates and compared its activity with erythromycin and other antibiotics. The work showed useful activity against many streptococci, staphylococci, Haemophilus influenzae, and Listeria, but substantially weaker performance than erythromycin and no activity against erythromycin-resistant isolates or most tested Enterobacteriaceae and Pseudomonas strains.

• MAPK10–KRT16 Signaling Limits NSCLC Metastasis

  2026-08-12

  The reference study identifies a phosphorylation-dependent MAPK10/KRT16/RNF213 pathway that restrains non-small cell lung cancer metastasis. Its combination of kinase-substrate analysis, ubiquitination studies, cell motility assays, animal rescue experiments, and clinical correlation provides a mechanistic framework for studying how post-translational control of keratin 16 influences metastatic behavior.

8068 records 4/538 page Previous Next 12345 下5页 Last page